Approval · Notice of Compliance 28646 · 2022
BURINEX: Notice of Compliance 28646
Issued July 21, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28646
- Date
- July 21, 2022
- Company
- Karo Pharma AbStockholm, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- BUMETANIDE 1 MG per TAB
- BUMETANIDE 5 MG per TAB